IBEX Enhanced X-ray Mammography
IBEX Enhanced X-ray Mammography
批准号:
105204
负责人:
金额:
$89.3万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
“该项目将开发和商业化新技术,从根本上提高x光乳房成像的安全性、有效性和患者舒适度。”首先,该项目将采用IBEX Trueview(r)无网格散射校正方法用于乳房x线照相术和数字乳房断层合成(DBT)系统,并证明其在乳房x线照相术和DBT重建中降低患者剂量和提高图像质量的有效性。在这个初始阶段产生的体内和离体数据将用于向领先的医疗x射线系统集成商推销能力,并在项目的第一年确保商业许可交易。其次,该项目将开发并演示3D x射线成像系统原型的有效性,该系统能够以比标准2D乳房x光检查更少的患者剂量创建完整的、高对比度的未压缩乳房3D重建,并且无需注射造影剂。这种激进的新产品有可能改变乳房筛查和癌症诊断,特别是对乳房致密的女性。在第二阶段收集的离体数据将用于告知商业化策略和未来的人体临床研究。”
英文摘要
"The project will develop and commercialise novel technologies to radically improve the safety, effectiveness and patient comfort of X-ray breast imaging.Firstly, the project will adapt the IBEX Trueview(r) gridless scatter correction method for use in mammography and Digital Breast Tomosynthesis (DBT) systems and demonstrate its effectiveness to reduce patient dose and improve image quality in mammograms and DBT reconstructions. The in-vivo and ex-vivo data generated during this initial phase will be used to market the capability to leading medical X-ray system integrators and secure commercial licence deals within the first year of the project.Secondly, the project will develop and demonstrate the effectiveness of a prototype 3D X-ray imaging system capable of creating full, high-contrast 3D reconstructions of uncompressed breasts at less patient dose than a standard 2D mammogram and without injected contrast agents. This radical new product has the potential to transform breast screening and cancer diagnosis, especially for women with dense breasts. The ex-vivo data collected during this second phase will be used to inform a commercialisation strategy and a future human clinical study."
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金